Robert M Plenge
Director; EVP, Chief Research Officer · 2 filings · Latest: Sep 10, 2026
BIOMARIN PHARMACEUTICAL INC
BRISTOL MYERS SQUIBB CO
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BMY | Robert M Plenge | EVP, Chief Research Officer | Mar 10, 2026 | Option Exercise | $0.00 | 17,501 | — | 31,600 |